Assessment and Monitoring of Onchocerciasis in Latin America

Advances in Parasitology

Volumn 77, Issue , 2011, Pages 175-226

  Rodríguez Pérez, Mario A ^a,c   Unnasch, Thomas R ^b   Real Najarro, Olga ^c,d  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Medicina UANL   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Black flies; Elimination of parasite transmission; Epidemiological surveillance; Molecular diagnosis; Neglected tropical diseases; Onchocerciasis programmes; Pool screening PCR; Vector borne diseases

Indexed keywords

AMIDINE; AMINOACETONITRILE; AMOCARZINE; ANTHELMINTIC AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CLOSANTEL; DIETHYLCARBAMAZINE; DOXYCYCLINE; GUANIDINE DERIVATIVE; HYDRAZONE DERIVATIVE; IMIDAZOLINYLHYDRAZONE; INSECTICIDE; IVERMECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OV33; NAFUREDIN; OV10 ANTIGEN; OV11 ANTIGEN; OV7 ANTIGEN; OXYTETRACYCLINE; PARASITE ANTIGEN; PYRIMIDINYLGUANIDINE; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN OV16; REPETITIVE DNA; RIFAMPICIN; TETRACYCLINE; THIADIAZOLE DERIVATIVE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTHELMINTIC ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHEMOTHERAPY; CLONE; CROSS REACTION; DEPIGMENTATION; DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DNA DETERMINATION; DNA PROBE; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HYPERKERATOSIS; HYPOTENSION; INFECTION CONTROL; INFECTION RISK; LICHENOID; MICROFILARIA; MOLECULAR LIBRARY; MUSCULOSKELETAL PAIN; NODULECTOMY; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OOCYTE DEVELOPMENT; OPTIC NERVE INJURY; OPTIC NEURITIS; PARASITE LOAD; PARASITE SURVIVAL; PARASITE VECTOR; PATCH TEST; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; POPULATION DENSITY DEPENDENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; SEROPREVALENCE; SIMULIUM; SIMULIUM ALBIVIRGULATUM; SIMULIUM CALLIDUM; SIMULIUM DAMNOSUM; SIMULIUM EXIGUUM; SIMULIUM GUIANENSE; SIMULIUM INCRUSTATUM; SIMULIUM LIMBATUM; SIMULIUM METALLICUM; SIMULIUM NEAVEI; SIMULIUM OCHRACEUM; SIMULIUM OYAPOCKENSE; SIMULIUM QUADRIVITTATUM; SIMULIUM SANCTIPAULI; SIMULIUM SQUAMOSUM; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ALLERGY; SKIN ATROPHY; SKIN BIOPSY; SKIN DEFECT; SOUTH AND CENTRAL AMERICA; SURGICAL TECHNIQUE; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; UVEA DISEASE; VECTOR CONTROL; VERTIGO; VISUAL IMPAIRMENT; WRINKLE; WUCHERERIA BANCROFTI;

EID: 82555192813     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-391429-3.00008-3     Document Type: Chapter

References (218)

1. Adjami A.G., Toe L., Bissan Y., Bugri S., Yameogo L., Kone M., et al. The current status of onchocerciasis in the forest/savannah transition zone of Cote d'Ivoire. Parasitology 2004, 128:407-414.
2. African Programme for Onchocerciasis Control, APOC Final Communiqué of the 11th Session of the Joint Action Forum of APOC, Paris, France 2005, APOC, Ouagadougou, Burkina Faso.
3. Alley W.S., van Oortmarssen G.J., Boatin B.A., Nagelkerke N.J., Plaisier A.P., Remme J.H., et al. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health 2001, 1:e12.
4. Amazigo U., Okeibunor J., Matovu V., Zoure H., Bump J., Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc. Sci. Med. 2007, 64:2070-2082.
5. Anderson J., Fuglsang H., Hamilton P.J., de Marshall T.F. Studies on onchocerciasis in the United Cameroon Republic. I. Comparison of populations with and without Onchocerca volvulus. Trans. R. Soc. Trop. Med. Hyg. 1974, 68:190-208.
6. Anderson R., May R., Anderson B. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University Press, Oxford, UK.
7. Andrews J.A., Bligh W.J., Chiodini P.L., Bradley J.E., Nde P.N., Lucius R. The role of a recombinant hybrid protein based ELISA for the serodiagnosis of Onchocerca volvulus. J. Clin. Pathol. 2008, 61:347-351.
8. Aoki Y., Sakamoto M., Yoshimura T., Tada I., Recinos M.M., Figueroa H. Onchocercomas in Guatemala, with special reference to appearance of new nodules and parasite content. Am. J. Trop. Med. Hyg. 1983, 32:741-746.
9. APOC Programme Document for Phase II [2002-2007] and the Phasing-Out Period [2008-2010] 2001, WHO, Geneva, JAP7.8, 49 pp.
10. Ardelli B.F., Stitt L.E., Tompkins J.B., Prichard R.K. A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans. Vet. Parasitol. 2009, 165:96-108.
11. Awadzi K., Opoku N.O., Attah S.K., Addy E.T., Duke B.O., Nyame P.K., et al. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Ann. Trop. Med. Parasitol. 1997, 91:281-296.
12. Ba O., Karam M., Remme J., Zerbo G. Role of children in the evaluation of the Onchocerciasis Control Program in West Africa. Trop. Med. Parasitol. 1987, 38:137-142.
13. Bandi C., Anderson T.J., Genchi C., Blaxter M.L. Phylogeny of Wolbachia in filarial nematodes. Proc. Biol. Sci. 1998, 265:2407-2413.
14. Bandi C., McCall J.W., Genchi C., Corona S., Venco L., Sacchi L. Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int. J. Parasitol. 1999, 29:357-364.
15. Barker R.H. Use of PCR in the field. Parasitol. Today 1994, 10:117-119.
16. Basáñez M.G., Boussinesq M. Population biology of human onchocerciasis. Philos. Trans. R. Soc. Lond. B 1999, 354:809-826.
17. Basáñez M.G., Ricardez-Esquinca J. Models for the population biology and control of human onchocerciasis. Trends Parasitol. 2001, 17:430-438.
18. Basáñez M.G., Rodriguez D. Dinámica de transmisión y modelos matemáticos en enfermedades transmitidas por vectores. Entomotropica 2004, 19:113-134.
19. Basáñez M.G., Yarzabal L., Takaoka H., Suzuki H., Noda S., Tada I. The vectoral role of several blackfly species (Diptera: Simuliidae) in relation to human onchocerciasis in the Sierra Parima and Upper Orinoco regions of Venezuela. Ann. Trop. Med. Parasitol. 1988, 82:597-611.
20. Basáñez M.G., Remme J.H., Alley E.S., Bain O., Shelley A.J., Medley G.F., et al. Density-dependent processes in the transmission of human onchocerciasis: relationship between the numbers of microfilariae ingested and successful larval development in the simuliid vector. Parasitology 1995, 110:409-427.
21. Basáñez M.G., Townson H., Williams J.R., Frontado H., Villamizar N.J., Anderson R.M. Density-dependent processes in the transmission of human onchocerciasis: relationship between microfilarial intake and mortality of the simuliid vector. Parasitology 1996, 113:331-355.
22. Basáñez M.G., Rodríguez-Pérez M.A., Reyes-Villanueva F., Collins R.C., Rodríguez M.H. Determination of sample sizes for the estimation of Onchocerca volvulus (Filarioidea: Onchocercidae) infection rates in biting populations of Simulium ochraceum s.l. (Diptera: Simuliidae) and its application to ivermectin control programs. J. Med. Entomol. 1998, 35:745-757.
23. Basáñez M.G., Collins R.C., Porter C.H., Little M.P., Brandling-Bennett D. Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am. J. Trop. Med. Hyg. 2002, 67:669-679.
24. Basáñez M.G., Pion S.D., Churcher T.S., Breitling L.P., Little M.P., Boussinesq M. River blindness: a success story under threat?. PLoS Med. 2006, 3:e371.
25. Basáñez M.G., Razali K., Renz A., Kelly D. Density-dependent host choice by disease vectors: epidemiological implications of the ideal free distribution. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:256-269.
26. Basáñez M.G., Pion S.D., Boakes E., Filipe J.A., Churcher T.S., Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:310-322.
27. Basáñez M.G., Churcher T.S., Grillet M.E. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv. Parasitol. 2009, 68:263-313.
28. Bloch P., Simonsen P.E., Weiss N., Nutman T.B. The significance of guinea worm infection in the immunological diagnosis of onchocerciasis and bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:518-521.
29. Boatin B. The Onchocerciasis Control Programme in West Africa (OCP). Ann. Trop. Med. Parasitol. 2008, 102:13-17.
30. Boatin B., Molyneux D.H., Hougard J.M., Christensen O.W., Alley E.S., Yameogo L., et al. Patterns of epidemiology and control of onchocerciasis in west Africa. J. Helminthol. 1997, 71:91-101.
31. Boatin B.A., Toe L., Alley E.S., Nagelkerke N.J., Borsboom G., Habbema J.D. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 2002, 125:545-552.
32. Botto C., Gillespie A.J., Vivas-Martinez S., Martinez N., Planchart S., Basanez M.G., et al. Onchocerciasis hyperendemic in the Unturan Mountains: the value of recombinant antigens in describing a new transmission area in southern Venezuela. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:25-30.
33. Botto C., Escalona E., Vivas-Martinez S., Behm V., Delgado L., Coronel P. Geographical patterns of onchocerciasis in southern Venezuela: relationships between environment and infection prevalence. Parassitologia 2005, 47:145-150.
34. Botto C., Escalona M., Cortés J., Torres J.F., Suárez L., Grillet M.E. Avances y desafíos en la producción de conocimientos y en la eliminación de la Oncocercosis en el Foco Sur de Venezuela, Salus. Revista de la Facultad de la Salud. Universidad de Carabobo, Valencia, Venezuela 2007, 11:9-14.
35. Bradley J.E., Unnasch T.R. Molecular approaches to the diagnosis of onchocerciasis. Adv. Parasitol. 1996, 37:57-106.
36. Bradley J.E., Helm R., Lahaise M., Maizels R.M. cDNA clones of Onchocerca volvulus low molecular weight antigens provide immunologically specific diagnostic probes. Mol. Biochem. Parasitol. 1991, 46:219-227.
37. Bradley J.E., Gillespie A.J., Trenholme K.R., Karam M. The effects of vector control on the antibody response to antigens of Onchocerca volvulus. Parasitology 1993, 106:363-370.
38. Bradley J.E., Trenholme K.R., Gillespie A.J., Guderian R., Titanji V., Hong Y., et al. A sensitive serodiagnostic test for onchocerciasis using a cocktail of recombinant antigens. Am. J. Trop. Med. Hyg. 1993, 48:198-204.
39. Bradley J.E., Atogho B.M., Elson L., Stewart G.R., Boussinesq M. A cocktail of recombinant Onchocerca volvulus antigens for serologic diagnosis with the potential to predict the endemicity of onchocerciasis infection. Am. J. Trop. Med. Hyg. 1998, 59:877-882.
40. Bradley J.E., Whitworth J., Basáñez M.G. Onchocerciasis. Topley and Wilson's Microbiology and Microbial Infections 2005, Edward Arnold Publishers Ltd., London, UK, 21pp. 10th ed. D. Wakelin, F. Cox, D. Despommier, S. Gillespie (Eds.).
41. Burbelo P.D., Leahy H.P., Iadarola M.J., Nutman T.B. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl. Trop. Dis. 2009, 3:e438.
42. Cabrera Z., Parkhouse R.M., Forsyth K., Gomez Priego A., Pabon R., Yarzabal L. Specific detection of human antibodies to Onchocerca volvulus. Trop. Med. Parasitol. 1989, 40:454-459.
43. Campbell W.C., Fisher M.H., Stapley E.O., Albers-Schonberg G., Jacob T.A. Ivermectin: a potent new antiparasitic agent. Science 1983, 221:823-828.
44. Carme B., Ntsoumou-Madzou V., Samba Y., Yebakima A. Prevalence of depigmentation of the shins: a simple and cheap way to screen for severe endemic onchocerciasis in Africa. Bull. World Health Organ. 1993, 71:755-758.
45. Chandrashekar R., Masood K., Alvarez R.M., Ogunrinade A.F., Lujan R., Richards F.O., et al. Molecular cloning and characterization of recombinant parasite antigens for immunodiagnosis of onchocerciasis. J. Clin. Invest. 1991, 88:1460-1466.
46. Chippaux J.P., Boussinesq M., Gardon J., Gardon-Wendel N., Ernould J.C. Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol. Today 1996, 12:448-450.
47. Churcher T.S., Basáñez M.G. Sampling strategies to detect anthelmintic resistance: the perspective of human onchocerciasis. Trends Parasitol. 2009, 25:11-17.
48. Churcher T.S., Ferguson N.M., Basáñez M.G. Density dependence and overdispersion in the transmission of helminth parasites. Parasitology 2005, 131:121-132.
49. Churcher T.S., Filipe J.A., Basáñez M.G. Density dependence and the control of helminth parasites. J. Anim. Ecol. 2006, 75:1313-1320.
50. Collins R.C., Lehmann T., Vieira Garcia J.C., Guderian R.H. Vector competence of Simulium exiguum for Onchocerca volvulus: implications for the epidemiology of onchocerciasis. Am. J. Trop. Med. Hyg. 1995, 52:213-218.
51. Cupp E.W. Treatment of Onchocerciasis with ivermectin in Central America. Parasitol. Today 1992, 8:212-214.
52. Cupp E.W., Cupp M.S. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am. J. Trop. Med. Hyg. 2005, 73:1159-1161.
53. Cupp E.W., Bernardo M.J., Kiszewski A.E., Collins R.C., Taylor H.R., Aziz M.A., et al. The effects of ivermectin on transmission of Onchocerca volvulus. Science 1986, 231:740-742.
54. Cupp E.W., Ochoa A.O., Collins R.C., Ramberg F.R., Zea G. The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus. Am. J. Trop. Med. Hyg. 1989, 40:501-506.
55. Cupp E.W., Ochoa J.O., Collins R.C., Cupp M.S., Gonzales-Peralta C., Castro J., et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am. J. Trop. Med. Hyg. 1992, 47:170-180.
56. Cupp E.W., Duke B.O., Mackenzie C.D., Guzman J.R., Vieira J.C., Mendez-Galvan J., et al. The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am. J. Trop. Med. Hyg. 2004, 71:602-607.
57. Dadzie Y., Neira M., Hopkins D. Final report of the conference on the eradicability of onchocerciasis. Filaria J. 2003, 2:e2.
58. Davies J.B. Description of a computer model of forest onchocerciasis transmission and its application to field scenarios of vector control and chemotherapy. Ann. Trop. Med. Parasitol. 1993, 87:41-63.
59. Davies J.B. Sixty years of onchocerciasis vector control: a chronological summary with comments on eradication, reinvasion, and insecticide resistance. Annu. Rev. Entomol. 1994, 39:23-45.
60. De Leon J.R., Duke B.O. Experimental studies on the transmission of Guatemalan and West African strains of Onchocerca volvulus by Simulium ochraceum. S. metallicum and S. callidum. Trans. R. Soc. Trop. Med. Hyg. 1966, 60:735-752.
61. Denery J.R., Nunes A.A., Hixon M.S., Dickerson T.J., Janda K.D. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl. Trop. Dis. 2010, 4:e834.
62. Diawara L., Traore M.O., Badji A., Bissan Y., Doumbia K., Goita S.F., et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
63. Donelson J.E., Duke B.O., Moser D., Zeng W.L., Erondu N.E., Lucius R., et al. Construction of Onchocerca volvulus cDNA libraries and partial characterization of the cDNA for a major antigen. Mol. Biochem. Parasitol. 1988, 31:241-250.
64. Duerr H.P., Dietz K., Eichner M. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 2005, 21:88-96.
65. Duerr H.P., Leary C.C., Eichner M. High infection rates at low transmission potentials in West African onchocerciasis. Int. J. Parasitol. 2006, 36:1367-1372.
66. Duke B.O. Human onchocerciasis-an overview of the disease. Acta Leiden. 1990, 59:9-24.
67. Duke B.O., Lewis D.J., Moore P.J. Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savannah strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones. Ann. Trop. Med. Parasitol. 1966, 60:318-326.
68. Edungbola L.D., Alabi T.O., Oni G.A., Asaolu S.O., Ogunbanjo B.O., Parakoyi B.D. 'Leopard skin' as a rapid diagnostic index for estimating the endemicity of African onchocerciasis. Int. J. Epidemiol. 1987, 16:590-594.
69. Engelbrecht F., Eisenhardt G., Turner J., Sundaralingam J., Owen D., Braun G., et al. Analysis of antibody responses directed against two Onchocerca volvulus antigens defined by monoclonal antibodies. Trop. Med. Parasitol. 1992, 43:47-53.
70. Erttmann K.D., Unnasch T.R., Greene B.M., Albiez E.J., Boateng J., Denke A.M., et al. A DNA sequence specific for forest form Onchocerca volvulus. Nature 1987, 327:415-417.
71. Erttmann K.D., Meredith S.E., Greene B.M., Unnasch T.R. Isolation and characterization of form specific DNA sequences of O. volvulus. Acta Leiden. 1990, 59:253-260.
72. Estambale B.B., Howells R.E. The efficacy of 22,23-dihydroavermectin B1 (Ivermectin) acting singly or in combination with a benzodiazepine on microfilariae of Onchocerca species and Brugia pahangi (an in vitro study). Zentralbl Bakteriol. 1989, 271:249-255.
73. Etya'ale D. Onchocerciasis and trachoma control: what has changed in the past two decades?. Community Eye Health 2008, 21:43-45.
74. Filipe J.A., Boussinesq M., Renz A., Collins R.C., Vivas-Martinez S., Grillet M.E., et al. Human infection patterns and heterogeneous exposure in river blindness. Proc. Natl. Acad. Sci. USA 2005, 102:15265-15270.
75. Forrester S.G., Prichard R.K., Dent J.A., Beech R.N. Haemonchus contortus: HcGluCla expressed in Xenopus oocytes forms a glutamate-gated ion channel that is activated by ibotenate and the antiparasitic drug ivermectin. Mol. Biochem. Parasitol. 2003, 129:115-121.
76. Freedman D.O., Unnasch T.R., Merriweather A., Awadzi K. Truly infection-free persons are rare in areas hyperendemic for African onchocerciasis. J. Infect. Dis. 1994, 170:1054-1055.
77. Garate T., Conraths F.J., Harnett W., Buttner D.W., Parkhouse R.M. Cloning of specific diagnostic antigens of Onchocerca volvulus. Trop. Med. Parasitol. 1990, 41:245-250.
78. Genchi C., Sacchi L., Bandi C., Venco L. Preliminary results on the effect of tetracycline on the embryogenesis and symbiotic bacteria (Wolbachia) of Dirofilaria immitis. An update and discussion. Parassitologia 1998, 40:247-249.
79. Gillespie A.J., Lustigman S., Rivas-Alcala A.R., Bradley J.E. The effect of ivermectin treatment on the antibody response to antigens of Onchocerca volvulus. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:456-460.
80. Gloeckner C., Garner A.L., Mersha F., Oksov Y., Tricoche N., Eubanks L.M., et al. Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc. Natl. Acad. Sci. USA 2010, 107:3424-3429.
81. Goa K.L., McTavish D., Clissold S.P. Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 1991, 42:640-658.
82. González R.J., Cruz-Ortiz N., Rizzo N., Richards J., Zea-Flores G., Domínguez A., et al. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl. Trop. Dis. 2009, 3:e404.
83. Greene B.M. Onchocerciasis. Tropical and Geographical Medicine 1990, 429-439. McGraw-Hill Inc., New York, USA. K.S. Warren, A.A.F. Mahmoud (Eds.).
84. Greene B.M., Kenneth R.B., Taylor H.R. Use of ivermectin in humans. Ivermectin and Abamectin 1989, 311-323. Springer Verlag Inc., New York, USA. W.C. Campbell (Ed.).
85. Grillet M.E., Basáñez M.G., Vivas-Martínez S., Villamizar N., Frontado H., Cortez J., et al. Human onchocerciasis in the Amazonian area of southern Venezuela: spatial and temporal variations in biting and parity rates of black fly (Diptera: Simuliidae) vectors. J. Med. Entomol. 2001, 38:520-530.
86. Guderian R.H. Effects of nodulectomy in onchocerciasis in Ecuador. Trop. Med. Parasitol. 1988, 39:356-357.
87. Guderian R.H., Proano R., Beck B., Mackenzie C.D. The reduction in microfilariae loads in the skin and eye after nodulectomy in Ecuadorian onchocerciasis. Trop. Med. Parasitol. 1987, 38:275-278.
88. Guderian R.H., Anselmi M., Chico M., Cooper P.J. Onchocerciasis in Ecuador: dermal depigmentation, leopard skin' and comparison with treponemal infection. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:639.
89. Guevara A.G., Vieira J.C., Lilley B.G., López A., Vieira N., Rumbea J., et al. Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am. J. Trop. Med. Hyg. 2003, 68:222-227.
90. Harnett W., Chambers A.E., Renz A., Parkhouse R.M. An oligonucleotide probe specific for Onchocerca volvulus. Mol. Biochem. Parasitol. 1989, 35:119-125.
91. Hoerauf A. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr. Opin. Infect. Dis. 2008, 21:673-681.
92. Hoerauf A., Marfo-Debrekyei Y., Buttner M., Debrah A.Y., Konadu P., Mand S., et al. Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus. Parasitol. Res. 2008, 103:279-286.
93. Hoerauf A., Specht S., Buttner M., Pfarr K., Mand S., Fimmers R., et al. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med. Microbiol. Immunol. 2008, 197:295-311.
94. Hoerauf A., Specht S., Marfo-Debrekyei Y., Buttner M., Debrah A.Y., Mand S., et al. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol. Res. 2009, 104:437-447.
95. Hotez P.J., Bottazzi M.E., Franco-Paredes C., Ault S.K., Periago M.R. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2008, 2:e300.
96. Hougard J.M., Alley E.S., Yameogo L., Dadzie K.Y., Boatin B.A. Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J. Infect. Dis. 2001, 184:497-503.
97. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., et al. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
98. Katholi C.R., Toe L., Merriweather A., Unnasch T.R. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J. Infect. Dis. 1995, 172:1414-1417.
99. Kilian H.D. The use of a topical Mazzotti test in the diagnosis of onchocerciasis. Trop. Med. Parasitol. 1988, 39:235-238.
100. Lammie P.J., Weil G., Noordin R., Kaliraj P., Steel C., Goodman D., et al. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis-a multicenter trial. Filaria J. 2004, 3:e9.
101. Langworthy N.G., Renz A., Mackenstedt U., Henkle-Dührsen K., de Bronsvoort M.B., Tanya V.N., et al. Macrofilaricidal activity of tetracycline against the filarial nematode, Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc. Biol. Sci. 2000, 267:1063-1069.
102. Lindblade K.A., Arana B., Zea-Flores G., Rizzo N., Porter C.H., Domínguez A., et al. Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am. J. Trop. Med. Hyg. 2007, 77:334-341.
103. Lipner E.M., Dembele N., Souleymane S., Alley W.S., Prevots D.R., Toe L., et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J. Infect. Dis. 2006, 194:216-221.
104. Little M.P., Basáñez M.G., Breitling L.P., Boatin B.A., Alley E.S. Incidence of blindness during the Onchocerciasis control programme in western Africa, 1971-2002. J. Infect. Dis. 2004, 189:1932-1941.
105. Little M.P., Breitling L.P., Basáñez M.G., Alley E.S., Boatin B.A. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 2004, 363:1514-1521.
106. Lobos E., Altmann M., Mengod G., Weiss N., Rudin W., Karam M. Identification of an Onchocerca volvulus cDNA encoding a low-molecular-weight antigen uniquely recognized by onchocerciasis patient sera. Mol. Biochem. Parasitol. 1990, 39:135-145.
107. Lobos E., Weiss N., Karam M., Taylor H.R., Ottesen E.A., Nutman T.B. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science 1991, 251:1603-1605.
108. Lucius R., Erondu N., Kern A., Donelson J.E. Molecular cloning of an immunodominant antigen of Onchocerca volvulus. J. Exp. Med. 1988, 168:1199-1204.
109. Lucius R., Schulz-Key H., Buttner D.W., Kern A., Kaltmann B., Prod'hon J., et al. Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody. J. Exp. Med. 1988, 167:1505-1510.
110. Lucius R., Kern A., Seeber F., Pogonka T., Willenbucher J., Taylor H.R., et al. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33). Trop. Med. Parasitol. 1992, 43:139-145.
111. Mackenzie C.D., Kron M.A. Diethylcarbamazine: a review of its action in onchocerciasis, lymphatic filarial and inflammation. Trop. Dis. Bull. 1985, 82:1-37.
112. Maia-Herzog M., Shelley A.J., Bradley J.E., Luna Dias A.P., Calvao R.H., Lowry C., et al. Discovery of a new focus of human onchocerciasis in central Brazil. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:235-239.
113. Maizels R.M., Bradley J.E., Helm R., Karam M. Immunodiagnosis of onchocerciasis: circulating antigens and antibodies to recombinant peptides. Acta Leiden. 1990, 59:261-270.
114. Marchon-Silva V., Caer J.C., Post R.J., Maia-Herzog M., Fernandes O. Detection of Onchocerca volvulus (Nematoda: Onchocercidae) infection in vectors from Amazonian Brazil following mass Mectizan distribution. Mem. Inst. Oswaldo Cruz 2007, 102:197-202.
115. Martín-Tellaeche A., Ramírez-Hernández J., Santos-Preciado J.I., Méndez-Galván J. Onchocerciasis changes in transmission in Mexico. Ann. Trop. Med. Parasitol. 1998, 1:117-119.
116. Mazzotti L. Posibilidad de utilizar como medio diagnóstico auxiliar en la oncocercosis, las reacciones alérgicas consecutivas a la administración del Hetrazán. Rev. Inst. Salubr. Enferm. Trop. 1948, 9:235-237.
117. McCall P.J. Oviposition aggregation pheromone in the Simulium damnosum complex. Med. Vet. Entomol. 1995, 9:101-108.
118. McCall P.J., Cameron M.M. Oviposition pheromones in insect vectors. Parasitol. Today 1995, 11:352-355.
119. McCall P.J., Trees A.J., Walsh J.F., Molyneux D.H. Aggregated oviposition in the Simulium damnosum complex is mediated by eggs in a laboratory bioassay. Med. Vet. Entomol. 1994, 8:76-80.
120. McCall P.J., Heath R.R., Dueben B.D., Wilson M.D. Oviposition pheromone in the Simulium damnosum complex: biological activity of chemical fractions from gravid ovaries. Physiol. Entomol. 1997, 22:224-230.
121. McCall P.J., Wilson M.D., Dueben B.D., de Clare Bronsvoort B.M., Heath R.R. Similarity in oviposition aggregation pheromone composition within the Simulium damnosum (Diptera: Simuliidae) species complex. Bull. Entomol. Res. 1997, 87:609-616.
122. Meredith S.E., Dull H.B. Onchocerciasis: the first decade of Mectizan™ treatment. Parasitol. Today 1998, 14:472-474.
123. Meredith S.E., Unnasch T.R., Karam M., Piessens W.F., Wirth D.F. Cloning and characterization of an Onchocerca volvulus specific DNA sequence. Mol. Biochem. Parasitol. 1989, 36:1-10.
124. Meredith S.E., Lando G., Gbakima A.A., Zimmerman P.A., Unnasch T.R. Onchocerca volvulus: application of the polymerase chain reaction to identification and strain differentiation of the parasite. Exp. Parasitol. 1991, 73:335-344.
125. Molyneux D.H. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:338-341.
126. Moore H.S., Noblet R. Flight range of Simulium slossonae, the vector of Lucocytozoon Smith of South Carolina. Environ. Entomol. 1974, 3:365-369.
127. Moraes M.A. Onchocerciasis among Yanomami Indians. Cad. Saude Publica 1991, 7:503-514.
128. Mouchet J., Teppaz M. Introduction of onchocerciasis in Central America: the role of the French expeditionary corps to Mexico (1861-1867). Bull. Soc. Pathol. Exot. 1993, 86:125-128.
129. Murdoch M.E., Hay R.J., Mackenzie C.D., Williams J.F., Ghalib H.W., Cousens S., et al. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br. J. Dermatol. 1993, 129:260-269.
130. Nde P.N., Pogonka T., Bradley J.E., Titanji V.P., Lucius R. Sensitive and specific serodiagnosis of onchocerciasis with recombinant hybrid proteins. Am. J. Trop. Med. Hyg. 2002, 66:566-571.
131. Newland H.S., Kaiser A., Taylor H.R. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. Trop. Med. Parasitol. 1987, 38:143-144.
132. Nutman T.B., Parredes W., Kubofcik J., Guderian R.H. Polymerase chain reaction-based assessment after macrofilaricidal therapy in Onchocerca volvulus infection. J. Infect. Dis. 1996, 173:773-776.
133. Ochoa J.O., Castro J.C., Barrios V.M., Juarez E.L., Tada I. Successful control of onchocerciasis vectors in San Vicente Pacaya, Guatemala, 1984-1989. Ann. Trop. Med. Parasitol. 1997, 91:471-479.
134. Ogunrinade A.F., Chandrashekar R., Weil G.J., Kale O.O. Use of a recombinant antigen (OC 3.6 cDNA) for the serological diagnosis of onchocerciasis in exposed Nigerian children. J. Trop. Pediatr. 1992, 38:103-105.
135. Ogunrinade A.F., Chandrashekar R., Eberhard M.L., Weil G.J. Preliminary evaluation of recombinant Onchocerca volvulus antigens for serodiagnosis of onchocerciasis. J. Clin. Microbiol. 1993, 31:1741-1745.
136. Omar M.S., Denke A.M., Raybould J.N. The development of Onchocerca ochengi (nematoda: filariodea) to the infective stage in Simulium damnosum s.l. with a note on the histochemical staining of the parasite. Tropenmed. Parasitol. 1979, 30:157-162.
137. Õmura S. Ivermectin: 25 years and still going strong. Int. J. Antimicrob. Agents 2008, 31:91-98.
138. Õmura S., Miyadera H., Ui H., Shiomi K., Yamaguchi Y., Masuma R., et al. An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Proc. Natl. Acad. Sci. USA 2001, 98:60-62.
139. Perler F.B., Karam M. Cloning and characterization of two Onchocerca volvulus repeated DNA sequences. Mol. Biochem. Parasitol. 1986, 21:171-178.
140. Pion S.D., Kaiser C., Boutros-Toni F., Cournil A., Taylor M.M., Meredith S.E., et al. Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl. Trop. Dis. 2009, 3:e461.
141. Poltera A.A., Poltera A.A. Onchocerciasis: bi-annual mass therapy or once every two years? Ivermectin versus possible amocarzine 1998.
142. Poltera A.A., Reyna O., Zea-Flores G., Beltranena F., Nowell de Arevalo A., Zak F. Use of an ophthalmologic ultrasound scanner in human onchocercal skin nodules for non-invasive sequential assessment during a macrofilaricidal trial with amocarzine in Guatemala. The first experiences. Trop. Med. Parasitol. 1991, 42:303-307.
143. Poltera A.A., Zea-Flores G., Guderian R., Beltranena F., Proana R., Moran M., et al. Onchocercacidal effects of amocarzine (CGP 6140) in Latin America. Lancet 1991, 337:583-584.
144. Porter C.H., Collins R.C. Seasonality of adult black flies and Onchocerca volvulus transmission in Guatemala. Am. J. Trop. Med. Hyg. 1988, 38:153-167.
145. Prost A. Le polymorphisme des onchocercoses humaines ouest-africaines. Ann. Parasitol. Hum. Comp. 1980, 55:239-245.
146. Ramachandran C.P. Improved immunodiagnostic tests to monitor onchocerciasis control programmes-a multicenter effort. Parasitol. Today 1993, 9:77-79.
147. Reiter P., Amador M.A., Colon N. Enhancement of the CDC ovitrap with hay infusions for daily monitoring of Aedes aegypti populations. J. Am. Mosq. Control Assoc. 1991, 7:52-55.
148. Remme J.H.F. The African Programme for Onchocerciasis Control: preparing to launch. Parasitol. Today 1995, 11:403-406.
149. Remme J.H.F., Feenstra P., Lever P.R., Medici A.C., Morel C.M., Noma M., et al. Tropical diseases targeted for elimination: chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. Disease Control Priorities in Developing Countries 2006, 433-450. Oxford University Press, Oxford, England. second ed. D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, P. Musgrove (Eds.).
150. Richards F.O., Amann J., Arana B., Punkosdy G., Klein R., Blanco C., et al. No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin. Am. J. Trop. Med. Hyg. 2007, 77:878-882.
151. Robles R. Onchocercose humaine au Guatémala produisant la cécité et Ierysipele du littoral (erisipela de la costa). Bull. Soc. Pathol. Exot. 1919, 12:442-463.
152. Rodríguez-Pérez M.A., Reyes-Villanueva F. The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico. Salud Publica Mex. 1994, 36:281-290.
153. Rodríguez-Pérez M.A., Rivas-Alcalá A.R. Problems in the investigation of the control of Onchocerca volvulus in Mexico. Salud Publica Mex. 1991, 33:493-503.
154. Rodríguez-Pérez M.A., Rodríguez-López M.H. Oncocercosis. En: Enfermedades Tropicales en México. Diagnóstico, Tratamiento y Distribución Geográfica. Oncocercosis 1994, 325-333. Instituto Nacional de Diagnóstico y Referencia Epidemiológicos de la Secretaría de Salud, México, DF. J.L. Valdespino-Gómez, O.V. Castrejón, A. Escobar-Gutiérrez, A. Del Río-Zolezzi, S. Ibáñez-Bernal, C. Magos-López (Eds.).
155. Rodríguez-Pérez M.A., Rodríguez M.H., Margeli-Pérez H.M., Rivas-Alcalá A.R. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am. J. Trop. Med. Hyg. 1995, 52:429-434.
156. Rodríguez-Pérez M.A., Danis-Lozano R., Rodríguez M.H., Bradley J.E. Application of an enzyme-linked immunosorbent assay to detect antibodies to Onchocerca volvulus on filter-paper blood spots: effect of storage and temperature on antibody decay. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:523-524.
157. Rodríguez-Pérez M.A., Danis-Lozano R., Rodríguez M.H., Bradley J.E. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. Trop. Med. Int. Health 1999, 4:98-104.
158. Rodríguez-Pérez M.A., Danis-Lozano R., Rodríguez M.H., Unnasch T.R., Bradley J.E. Detection of Onchocerca volvulus infection in Simulium ochraceum sensu lato: comparison of a PCR assay and fly dissection in a Mexican hypoendemic community. Parasitology 1999, 119:613-619.
159. Rodríguez-Pérez M.A., Domínguez-Vázquez A., Mendez-Galvan J., Sifuentes-Rincon A.M., Larralde-Corona P., Barrera-Saldana H.A., et al. Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapid-format antibody card test. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:539-541.
160. Rodríguez-Pérez M.A., Lilley B.G., Domínguez-Vázquez A., Segura-Arenas R., Lizarazo-Ortega C., Mendoza-Herrera A., et al. Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico. Am. J. Trop. Med. Hyg. 2004, 70:38-45.
161. Rodríguez-Pérez M.A., Katholi C.R., Hassan H.K., Unnasch T.R. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am. J. Trop. Med. Hyg. 2006, 74:1026-1033.
162. Rodríguez-Pérez M.A., Lugo-Rodríguez L., Lizarazo-Ortega C., Unnasch T.R. Entomologic and serologic assessment of Onchocerca volvulus transmission in the Northern Chiapas focus (Mexico). Acta Entomol. Serb. 2006, (Suppl.):51-59.
163. Rodríguez-Pérez M.A., Núñez-González C.A., Lizarazo-Ortega C., Sánchez-Varela A., Wooten M.C., Unnasch T.R. Analysis of genetic variation in ribosomal DNA internal transcribed spacer and the NADH dehydrogenase subunit 4 mitochondrial genes of the onchocerciasis vector Simulium ochraceum. J. Med. Entomol. 2006, 43:701-706.
164. Rodríguez-Pérez M.A., Cabrera A.S., Ortega C.L., Basáñez M.G., Davies J.B. Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico. Filaria J. 2007, 6:16.
165. Rodríguez-Pérez M.A., Lizarazo-Ortega C., Hassan H.K., Domínguez-Vásquez A., Mendez-Galván J., Lugo-Moreno P., et al. Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico. Am. J. Trop. Med. Hyg. 2008, 78:147-152.
166. Rodríguez-Pérez M.A., Lutzow-Steiner M.A., Segura-Cabrera A., Lizarazo-Ortega C., Domínguez-Vázquez A., Sauerbrey M., et al. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan. Am. J. Trop. Med. Hyg. 2008, 79:239-244.
167. Rodríguez-Pérez M.A., Unnasch T.R., Domínguez-Vázquez A., Morales-Castro A.L., Pena-Flores G.P., Orozco-Algarra M.E., et al. Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico. Am. J. Trop. Med. Hyg. 2010, 83:21-27.
168. Rodríguez-Pérez M.A., Unnasch T.R., Domínguez-Vázquez A., Morales-Castro A.L., Richards F., Peña-Flores G.P., et al. Lack of active Onchocerca volvulus transmission in the northern Chiapas focus of Mexico. Am. J. Trop. Med. Hyg. 2010, 83:15-20.
169. Ros-Moreno R.M., Moreno-Guzman M.J., Jiménez-Gonzalez A., Rodríguez-Caabeiro F. Interaction of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae. Parasitol. Res. 1999, 85:320-323.
170. Saint Andre A., Blackwell N.M., Hall L.R., Hoerauf A., Brattig N.W., Volkmann L., et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002, 295:1892-1895.
171. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann. Trop. Med. Parasitol. 2008, 1:25-29.
172. Schulz-Key H. Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden. 1990, 59:27-44.
173. Schwartz D.A., Brandling-Bennett A.D., Figueroa H., Connor D.H., Gibson D.W. Sowda-type onchocerciasis in Guatemala. Acta Trop. 1983, 40:383-389.
174. Shah J.S., Karam M., Piessens W.F., Wirth D.F. Characterization of an Onchocerca-specific DNA clone from Onchocerca volvulus. Am. J. Trop. Med. Hyg. 1987, 37:376-384.
175. Shelley A.J. Vector aspects of the epidemiology of onchocerciasis in Latin America. Annu. Rev. Entomol. 1988, 33:337-366.
176. Shelley A.J. Simuliidae and the transmission and control of human onchocerciasis in Latin America. Cad. Saude Publica 1991, 7:310-327.
177. Shelley A.J., Arzube M. Studies on the biology of Simuliidae (Diptera) at the Santiago onchocerciasis focus in Ecuador, with special reference to the vectors and disease transmission. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:328-338.
178. Specht S., Mand S., Marfo-Debrekyei Y., Debrah A.Y., Konadu P., Adjei O., et al. Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus. Parasitol. Res. 2008, 103:1303-1309.
179. Stingl P., Ross M., Gibson D.W., Ribas J., Connor D.H. A diagnostic "patch test" for onchocerciasis using topical diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 1984, 78:254-258.
180. Stolk W.A., de Vlas S.J., Habbema J.D. Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling. Filaria J. 2006, 5:e5.
181. Strote G., Bonow I., Kromer M., Rubio de Kromer T., Attah S., Opoku N. Chemotherapy for onchocerciasis: results of in vitro experiments with promising new compounds. Trop. Med. Int. Health 1998, 3:397-407.
182. Takaoka H. Seasonal occurrence of Simulium ochraceum, the principal vector of Onchocerca volvulus in the southeastern endemic area of Guatemala. Am. J. Trop. Med. Hyg. 1981, 30:1121-1132.
183. Takaoka H., Suzuki H., Noda S., Tada I., Basáñez M.G., Yarzabal L. Development of Onchocerca volvulus larvae in Simulium pintoi in the Amazonas region of Venezuela. Am. J. Trop. Med. Hyg. 1984, 33:414-419.
184. Taylor H.R., Greene B.M. Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis. Br. J. Ophthalmol. 1981, 65:494-502.
185. Taylor H.R., Keyvan-Larijani E., Newland H.S., White A.T., Greene B.M. Sensitivity of skin snips in the diagnosis of onchocerciasis. Trop. Med. Parasitol. 1987, 38:145-147.
186. Taylor H.R., Munoz B., Keyvan-Larijani E., Greene B.M. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am. J. Trop. Med. Hyg. 1989, 41:467-471.
187. Taylor M.J., Awadzi K., Basáñez M.G., Biritwum N., Boakye D., Boatin B., et al. Onchocerciasis control: vision for the future from a Ghanian perspective. Parasites Vectors 2009, 2:e7.
188. Thylefors B. Ocular onchocerciasis. Bull. World Health Organ. 1978, 56:63-73.
189. Toe L., Merriweather A., Unnasch T.R. DNA probe-based classification of Simulium damnosum s. l.-borne and human-derived filarial parasites in the onchocerciasis control program area. Am. J. Trop. Med. Hyg. 1994, 51:676-683.
190. Toe L., Back C., Adjami A.G., Tang J.M., Unnasch T.R. Onchocerca volvulus: comparison of field collection methods for the preservation of parasite and vector samples for PCR analysis. Bull. World Health Organ. 1997, 75:443-447.
191. Toe L., Tang J., Back C., Katholi C.R., Unnasch T.R. Vector-parasite transmission complexes for onchocerciasis in West Africa. Lancet 1997, 349:163-166.
192. Trenholme K.R., Tree T.I., Gillespie A.J., Guderian R., Maizels R.M., Bradley J.E. Heterogeneity of IgG antibody responses to cloned Onchocerca volvulus antigens in microfiladermia positive individuals from Esmeraldas Province, Ecuador. Parasite Immunol. 1994, 16:201-209.
193. Unnasch T.R., Meredith S.E. The use of degenerate primers in conjunction with strain and species oligonucleotides to classify Onchocerca volvulus. Methods Mol. Biol. 1996, 50:293-303.
194. Unnasch T.R., Williams S.A. The genomes of Onchocerca volvulus. Int. J. Parasitol. 2000, 30:543-552.
195. Vieira J.C., Brackenboro L., Porter C.H., Basáñez M.G., Collins R.C. Spatial and temporal variation in biting rates and parasite transmission potentials of onchocerciasis vectors in Ecuador. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:178-195.
196. Vieira J.C., Cooper P.J., Lovato R., Mancero T., Rivera J., Proano R., et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med. 2007, 5:e9.
197. Vivas-Martínez S., Grillet M.E., Botto C., Basáñez M.G. La oncocercosis humana en el foco amazónico. Bol. Mal. Salud Amb. 2007, 47:15-46.
198. Wahl G., Schibel J.M. Onchocerca ochengi: morphological identification of the L3 in wild Simulium damnosum s.l., verified by DNA probes. Parasitology 1998, 116:337-348.
199. Wahl G., Ekale D., Schmitz A. Onchocerca ochengi: assessment of the Simulium vectors in north Cameroon. Parasitology 1988, 116:327-336.
200. Wandji K., Cesbron J.Y., Dissous C., Taylor D.W., Haque A., Lutsch C., et al. Use of monoclonal antibodies for the characterization of Onchocerca volvulus antigens. Trop. Med. Parasitol. 1990, 41:13-19.
201. Weil G.J., Ogunrinade A.F., Chandrashekar R., Kale O.O. IgG4 subclass antibody serology for onchocerciasis. J. Infect. Dis. 1990, 161:549-554.
202. Weil G.J., Steel C., Liftis F., Li B.W., Mearns G., Lobos E., et al. A rapid-format antibody card test for diagnosis of onchocerciasis. J. Infect. Dis. 2000, 182:1796-1799.
203. WER Onchocerciasis (river blindness). Report from the eighteenth Inter-American Conference on Onchocerciasis, November 2008. Wkly. Epidemiol. Rec. 2009, 84:385-389.
204. WER Report from the 2009 Inter-American Conference on Onchocerciasis: progress towards eliminating river blindness in the region of the Americas. Wkly. Epidemiol. Rec. 2010, 85:321-328.
205. WER InterAmerican Conference on Onchocerciasis, 2010: progress towards eliminating river blindness in the WHO Region of the Americas. Wkly. Epidemiol. Rec. 2011, 86(38):417-424.
206. Wetten S., Collins R.C., Vieira J.C., Marshall C., Shelley A.J., Basáñez M.G. Vector competence for Onchocerca volvulus in the Simulium (Notolepria) exiguum complex: cytoforms or density-dependence?. Acta Trop. 2007, 103:58-68.
207. Whitworth J. Onchocerciasis. Microbiology and Microbial Infections 1988, Topley and Wilson's (Arnold), London, UK. F.E.G. Cox, J.P. Kreier, D.E.V.P. Wakelin, L. Collier, A. Balows, M.G.E. Sussman (Eds.).
208. WHO WHO Expert Committee on Onchocerciasis. Third report. World Health Organ. Tech. Rep. Ser. 1987, 752:1-167.
209. WHO Executive summary 1991, 36pp.
210. WHO Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ. Tech. Rep. Ser. 1995, 852:1-104.
211. WHO Blindness and Visual Disability: Part IV of VII: Socioeconomic Aspects 1997, WHO Fact Sheet No. 145, 3pp.
212. WHO Certification of Elimination of Human Onchocerciasis: Criteria and Procedures 2001, WHO, Geneva, Document WHO/CDS/CPE/CEE/2001.18b, 36pp.
213. Woodruff A.W., Choyce D.P., Muci-Mendoza F., Hills M., Pettit L.E. Onchocerciasis in Guatemala. A clinical and parasitological study with comparisons between the disease there and in East Africa. Trans. R. Soc. Trop. Med. Hyg. 1966, 60:707-719.
214. Yaméogo L., Toè L., Hougard J.M., Boatin B.A., Unnasch T.R. Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnosum sensu lato: results of a field trial in an area subject to successful vector control. Am. J. Trop. Med. Hyg. 1999, 60:124-128.
215. Zak F., Guderian R., Zea-Flores G., Guevara A., Moran M., Poltera A.A. Microfilaricidal effect of amocarzine in skin punch biopsies of patients with onchocerciasis from Latin America. Trop. Med. Parasitol. 1991, 42:294-302.
216. Zimmerman P.A., Toe L., Unnasch T.R. Design of Onchocerca DNA probes based upon analysis of a repeated sequence family. Mol. Biochem. Parasitol. 1993, 58:259-267.
217. Zimmerman P.A., Guderian R.H., Aruajo E., Elson L., Phadke P., Kubofcik J., et al. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J. Infect. Dis. 1994, 169:686-689.
218. Zimmerman P.A., Katholi C.R., Wooten M.C., Lang-Unnasch N., Unnasch T.R. Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol. Biol. Evol. 1994, 11:384-392.